此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

SettleIN - Adjustment to Care in Dementia: An Intervention Feasibility Study v0.1

2021年8月5日 更新者:University College, London

SettleIN - An Adjustment to Care Intervention for People With Dementia: A Feasibility Pilot Study in Care Homes

Admission into a care home for people with dementia has been linked with both positive and negative psychological outcomes for both the resident and their carers. Whilst some people with dementia adjust quickly, many never adjust at all or adjustment is complex and linked to cognitive and behavioural decline (Wilson et al, 2007). Therefore, support for healthy adjustment is needed.

Recent research (Aminzadeh et al., 2013; Sury, Burns and Brodaty, 2013, Sussman and Dupuis, 2013) has identified factors that influence different relocation outcomes and prevent adverse reactions. There are currently no interventions that support successful adjustment by emphasising the positive factors found to influence relocation outcomes while mitigating the effects of negative influences and addressing any missed pre-admission procedures, reported in the literature.

The current project seeks to design an intervention that predominantly builds on the work of Sury et al (2013) and focuses on promoting healthy adjustment through an enhanced best practice based admission process.

The intervention will be developed through systematic review of the literature and consultation with professional experts, service users, care home staff and carers. The current study will serve as a feasibility (pilot) study and test the acceptability of the intervention design, examine recruitment and dropout and establish sample size for future, larger studies. It also aims to examine whether the intervention indicates an improvement in residents' quality of life, mood, overall adjustment and carer satisfaction with care.

All participants will receive a subset of the same intervention, specifically tailored to their needs and with elements delivered by staff, carer or psychologist. Staff and researchers will assess the improvement indicators mentioned above using relevant psychometric measures at baseline, post intervention completion and at one-month follow up. Indirect measures (interviews and staff field notes) will also be used to indicate intervention fidelity and feasibility.

研究概览

地位

招聘中

条件

研究类型

介入性

注册 (预期的)

24

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

学习地点

      • London、英国
        • 招聘中
        • Multiple UK Care Home locations
        • 接触:
          • Janine Hayward

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

65年 及以上 (年长者)

接受健康志愿者

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Site:

    • Within Greater London
    • At least one resident who has been recently admitted to care (ideally within the previous fortnight and no more than one month after admission).
    • Sufficient cover to allow at least 1 staff lead to attend a half-day training
    • Managerial assurance of adequate resources allowing staff participation

Resident sample:

  • Meet diagnostic criteria for dementia according to the Diagnostic and Statistical Manual of Mental Disorders V (DSM-V, APA, 2013)
  • Score between FAST stage 2 and 6 representing a range of mild to moderately severe dementia on The Functional Assessment Staging Test (FAST, Reisberg, 1987)
  • Be able to communicate in English

Staff sample:

• Working as a Nurse (registered nurses of any grade, student nurses) or Care Assistant (Health Care Assistants and nursing assistants).

DSM Criteria will be confirmed by formal diagnosis or use of the FAST as a screen.

Exclusion Criteria:

Site:

• Participation in any other research study

Resident sample:

• Score FAST stage 7 equating to severe dementia on The Functional Assessment Staging Test (FAST, Reisberg, 1987)

Staff sample:

• Lack of availability on training, intervention delivery and assessment dates

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:支持治疗
  • 分配:不适用
  • 介入模型:单组作业
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:SettleIN
SettleIN - Adjustment to care programme intervention
A programme for care home staff to support new residents with dementia quickly and successfully adjust to life in a care home

研究衡量的是什么?

主要结果指标

结果测量
大体时间
The primary outcome measure is change in residents' quality of life and measured by the Quality of Life in Alzheimer's Disease (QOL-AD, Lodgson et al, 1996) which will be administered by researchers.
大体时间:Baseline, post intervention (4-6 weeks after intervention start) and at one month follow up
Baseline, post intervention (4-6 weeks after intervention start) and at one month follow up

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Aimee Spector、UCL London

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2015年7月27日

初级完成 (预期的)

2022年12月1日

研究完成 (预期的)

2023年12月1日

研究注册日期

首次提交

2016年1月22日

首先提交符合 QC 标准的

2016年2月10日

首次发布 (估计)

2016年2月15日

研究记录更新

最后更新发布 (实际的)

2021年8月9日

上次提交的符合 QC 标准的更新

2021年8月5日

最后验证

2021年8月1日

更多信息

与本研究相关的术语

其他研究编号

  • 15/0201
  • 15/LO/0611 (其他标识符:NRES Committee London - Camden & Kings Cross)

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

IPD 计划说明

Anonymised and summarised data is planned for inclusion in an empirical paper to be submitted for publication. The summarised results will be fed back to participating care home managers and staff if desired.

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

SettleIN - Adjustment to care programme的临床试验

  • Hospital Universitario Infanta Leonor
    Fundacion SEIMC-GESIDA; Instituto de Salud Carlos III
    完全的
    丙型肝炎 | 艾滋病病毒 | 减低危害 | 吸毒者
  • Wake Forest University Health Sciences
    National Cancer Institute (NCI)
    完全的
    复发性头颈部鳞状细胞癌 | 复发性下咽鳞状细胞癌 | 复发性喉鳞状细胞癌 | 照顾者 | 唾液腺鳞状细胞癌 | 恶性头颈肿瘤 | 复发性唇和口腔鳞状细胞癌 | IV 期下咽鳞状细胞癌 | IVA 期喉鳞状细胞癌 | IVA 期唇和口腔鳞状细胞癌 | IVA 期口咽鳞状细胞癌 | IVB期喉鳞状细胞癌 | IVB 期唇和口腔鳞状细胞癌 | IVB 期口咽鳞状细胞癌 | IVC 期喉鳞状细胞癌 | IVC 期唇和口腔鳞状细胞癌 | IVC 期口咽鳞状细胞癌 | 鼻窦鳞状细胞癌 | I 期下咽鳞状细胞癌 | I期喉鳞状细胞癌 | I 期唇和口腔鳞状细胞癌 | I期口咽鳞状细胞癌 | II期下咽鳞状细胞癌 | II期喉鳞状细胞癌 | II 期唇和口腔鳞状细胞癌 | II期口咽鳞状细胞癌 | III 期下咽鳞状细胞癌 | III期喉鳞状细胞癌 | III... 及其他条件
    美国
3
订阅